New Medicare Approval Requirement Delays Treatment
Some people living with migraine disease and movement disorders are finding it takes longer to get treatment, if they can even access it at all.
Cancer and the COVID-19 Disruption
Americans have postponed cancer screenings and other cancer care to avoid COVID-19 exposure, new data confirms. But they may inadvertently be trading one health risk for another.
Vision Impairment to Double by 2050
A new study predicts an alarming increase in global vision impairment.
Survey: Pandemic Complicates Migraine Disease Care
The COVID-19 pandemic has made managing migraine disease more difficult, according to a new national survey of patients.
RSV Isn’t COVID-19, But It’s Just as Serious
This fall, parents may worry over every cough or sniffle, as well they should. Even if it’s not COVID-19, it could be something just as dangerous – RSV.
Sixth Annual Infant Health Policy Summit
The sixth annual Infant Health Policy Summit welcomed health care providers, parents, policymakers, advocates and other stakeholders to explore how policy solutions can improve the health and lives of infants and their families. This year’s event, held virtually, examined issues such as: Late preterm infants Respiratory syncytial virus and COVID-19 Isolation and disruption during COVID-19 […]
Telemedicine’s Uncertain Future
The ability to connect with health care providers via phone, laptop or tablet has become a lifeline for patients during the COVID-19 pandemic.
New Treatment Could Help Infants with Rare Disease
Families of infants with a rare and devastating metabolic disease could soon have their first chance at treatment.
World Sight Day Sheds Light on Eye Health
More than 2 billion people globally have a vision impairment – nearly half of which could have been prevented or have yet to be addressed.
Congress Spotlights Migraine’s Impact on Women
A first-of-its-kind congressional resolution is shedding light on how migraine disease impacts millions of Americans, many of them women.
